Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism.
about
Hyperparathyroidism of Renal DiseaseSurgical management of secondary hyperparathyroidism in chronic kidney disease--a consensus report of the European Society of Endocrine Surgeons.Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism.Percutaneous ethanol injection therapy for advanced renal hyperparathyroidism in Japan: 2004 survey by the Japanese Society for Parathyroid InterventionLong-term prognosis of parathyroid function in chronic dialysis patients after PEIT-a single-centre trial.The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism.Efficacy of intraoperative parathyroid hormone monitoring to predict success of parathyroidectomy for secondary hyperparathyroidism.The role of preoperative ultrasonography, computed tomography, and sestamibi scintigraphy localization in secondary hyperparathyroidism.Medical therapy of secondary hyperparathyroidism in chronic kidney disease: old and new drugs.Surgical treatment of secondary hyperparathyroidism due to chronic kidney disease.Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidismParathyroid ultrasonography and bone metabolic profile of patients on dialysis with hyperparathyroidism.Pharmacotherapy and interventional treatments for secondary hyperparathyroidism: current therapy and future challenges.Diseases of the parathyroid gland in chronic kidney disease.Mineral and bone disorders in kidney transplant recipients: reversible, irreversible, and de novo abnormalities.Cinacalcet and Clinical Outcomes in Dialysis.Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease.Surgical management of secondary hyperparathyroidism: how to effectively reduce recurrence at the time of primary surgery.Ultrasound-based scores as predictors for nodular hyperplasia in patients with secondary hyperparathyroidism: a prospective validation study.New clinical guidelines for selective direct injection therapy of the parathyroid glands in chronic dialysis patients.The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism.Clinical significance of parathyroid intervention on CKD-MBD management.Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention.Association between long-term efficacy of cinacalcet and parathyroid gland volume in haemodialysis patients with secondary hyperparathyroidism.Indication and efficacy of PEIT in the management of secondary hyperparathyroidism.[Management of secondary hyperparathyroidism-current impact of parathyroidectomy].Subtotal Parathyroidectomy and Relocation of the Parathyroid Remnant for Renal Hyperparathyroidism: modification of a traditional operation.Risk-factors for nodular hyperplasia of parathyroid glands in sHPT patients.Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.4D-CT for preoperative localization of abnormal parathyroid glands in patients with hyperparathyroidism: accuracy and ability to stratify patients by unilateral versus bilateral disease in surgery-naive and re-exploration patients.Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients--results of the Austrian cohort of the ECHO study.Clinicopathological analysis of persistent hypercalcemia and hyperparathyroidism after kidney transplantation in long-term dialysis patients.Parathyroid Nodular Hyperplasia and Responsiveness to Drug Therapy in Renal Secondary Hyperparathyroidism: An Open Question.Tertiary hyperparathyroidism resistant to cinacalcet treatment.Role of multifunctional cell cycle modulators in advanced secondary hyperparathyroidism.Development and prevention of morphologic and ultrastructural changes in uremia-induced hyperplastic parathyroid gland.Two Years of Cinacalcet Hydrochloride Treatment Decreased Parathyroid Gland Volume and Serum Parathyroid Hormone Level in Hemodialysis Patients With Advanced Secondary Hyperparathyroidism.Postoperative hungry bone syndrome in patients with secondary hyperparathyroidism of renal origin.
P2860
Q28068593-829BBB50-9D84-492E-8420-C0528031A103Q30316084-16F890FB-5861-4958-A687-45C0B59D826CQ34362759-47EEADE9-2364-4B3F-B09F-1629599B7ABEQ35573604-972127B5-6372-47A2-9593-174C7DC9ECA5Q35573606-DDB29934-A603-4884-AF32-8230CEE1136AQ35928870-68339AAA-C92E-4D9B-9DB8-0CDE65B67358Q36083561-68DC044C-447B-41F5-8C57-C4F014099E0DQ36352985-43F84676-FE5E-4E23-8AFD-5268D95BBE50Q36632228-268D5450-61F6-466F-8351-AD44E415983AQ36853299-0A8942DF-EED1-475F-8F5B-9E6752128105Q37102086-663AA1E4-E0DD-4701-A2A6-71BE7DFF19E5Q37231801-1D870D59-85D8-492F-92E1-057B2DA88E47Q37807991-C14D5546-D278-4346-9591-0771009C6B4CQ37912038-9BEE6682-9B32-4F43-843C-6431F9EB38CBQ38452732-9EE98FF5-07DB-4B76-8FE4-3BFAF7DF8705Q38565049-1677131F-9056-4763-A2B5-91D103528E7DQ38572880-5847C8CA-3610-4517-9876-BA9C626B5C46Q38653889-E9DA755B-2C48-451E-A7B1-A38A00731F36Q39039175-23ED76CA-4A3A-4005-A55B-03384456AFAEQ40318080-BCCFF947-E1BD-4916-A6D8-C7AA8869BED3Q40318220-E6C82EAE-46D3-4CD2-8CFE-28645EC32E89Q40318270-57E6FE0C-1331-4216-B291-8334018C42D5Q40318301-23ED9BD1-4558-46F7-B3C3-A7C8E0D573B0Q40318370-6CB30E8A-9E7A-472A-8DDF-281A3F6383F3Q40318401-54772B3E-966A-410A-B363-0F4CCD20FB89Q40889096-08DF47B4-6536-465D-89DF-A52B9D221570Q42644043-25A08995-3E5F-4309-90A9-F470F60E0616Q42685461-D27497BE-C3BB-42F2-BB61-F37636255DE0Q43427754-4EB8D153-D03F-4409-ADCB-121F20DF47FDQ44167388-EB761BF2-FCBC-47AB-9C5F-49694760BBF7Q44186583-70C19F9B-5593-494E-97CD-93B8C7384BBAQ44957374-02D87DDA-D946-49CA-8782-A9ED92D1EEF0Q48239717-04456B6D-5ED3-4A21-9222-F49F88B320E5Q50535364-F761FF8A-1A28-4845-8D29-69C18654AF1DQ50535369-0C7CEE37-8DDE-40FE-B99E-C7DFE0D98C0EQ53223709-B34D31FA-1458-42E4-9329-4B1F9D21A140Q53551519-22769393-04D5-4857-99B4-C49E580054C5Q53648647-B0936EAB-0B0C-470F-B90B-AB909101DB62
P2860
Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Histopathology, pathophysiolog ...... of renal hyperparathyroidism.
@en
type
label
Histopathology, pathophysiolog ...... of renal hyperparathyroidism.
@en
prefLabel
Histopathology, pathophysiolog ...... of renal hyperparathyroidism.
@en
P2093
P1476
Histopathology, pathophysiolog ...... of renal hyperparathyroidism.
@en
P2093
P2860
P356
10.1002/(SICI)1098-2388(199703/04)13:2<78::AID-SSU3>3.0.CO;2-Z
P577
1997-03-01T00:00:00Z